eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Reconstructive Surgery
Bell Palsy
Updated: Nov 21, 2007
Introduction
Background
Bell palsy, more appropriately known as idiopathic facial paralysis (IFP), is believed to be a virally mediated cranial neuritis affecting the facial nerve due to reactivation of the herpes simplex virus (HSV). IFP accounts for approximately 60-75% of cases of acute facial palsies.
The minimum diagnostic criteria include paralysis or paresis of all muscle groups on one side of the face, sudden onset, and absence of CNS disease. Note that the diagnosis of IFP is made only after other causes of acute peripheral palsy have been excluded.
The treatment of IFP is also controversial, with steroids and antivirals as well as surgical intervention as the mainstay of current therapy. Most patients recover completely with or without treatment. Variable manifestations include otalgia, hyperacusis, decreased tearing, dysgeusia, facial or retroauricular pain, and other cranial neuropathies.
People with acute facial paralysis have a difficult emotional, psychological, and physical challenge. The physicians treating IFP must take into account the aesthetic, functional, and emotional needs of the affected patient. They must be familiar with the natural history of the disease process if they are to counsel the patients effectively about their expectations for recovery and the prevention of complications associated with the paralysis.
Pathophysiology
The exact etiology of IFP remains controversial. Proposed etiologies include viral infection, vascular compromise, autoimmune disease, allergy, and infectious agents. The exact mechanism has not yet been elucidated. The most widely accepted etiology for IFP is a virally mediated cranial neuritis, the agent being herpes simplex virus. This has been demonstrated by numerous serologic, animal, and human studies. Additional support for a viral etiology was seen when intranasal inactivated influenza vaccine was strongly linked to the development of Bell palsy, although whether another component of the vaccine caused the paresis, which was then accompanied by a reactivation of herpes simplex virus, is not clear. Recently, a large population based study found no evidence of increased risk of facial paralysis following pneumococcal vaccine administration.
Frequency
United States
Incidence of IFP is 20-30 patients per 100,000 population. Positive family history of IFP is identified in 8% of patients.
Very few cases are observed during the summer months.
Higher incidence is observed during pregnancy, especially with concurrent preeclampsia.
More people first notice paresis in the morning. Because paresis requires several hours to become evident, it appears that most paresis occurs during sleep.
Mortality/Morbidity
Patients with Bell palsy face a difficult emotional, psychological, and physical challenge. Paralysis, otalgia, decreased tearing, hyperacusis, dysgeusia, facial or retroauricular pain, and other cranial neuropathies may be present.
Bell palsy tends to recur in 7-9% of patients diagnosed with this condition, usually in patients with a family history of IFP or diabetes mellitus.
Sex
The male-to-female ratio is approximately equal, with a slight female predominance in patients younger than 20 years and a slight male predominance in patients older than 40 years.
Age
- The mean age at onset is early to mid forties.
- Slightly higher predominance is observed in patients older than 65 years (59 cases per 100,000 people).
- Lower rate of incidence is observed in children younger than 13 years (13 cases per 100,000 people).
Clinical
History
IFP is a diagnosis of exclusion. All other etiologies of facial paralysis, including traumatic, neoplastic, infectious, congenital, metabolic, immunologic, and autoimmune, should be ruled out.
- Paralysis or paresis of all the muscle groups on one side of the face may occur.
- The onset may be sudden, usually less than 48 hours.
- No evidence of CNS disease is noted. No evidence of ear or cerebellopontine angle disease is noted.
- It may follow recent upper respiratory infection (URI).
- Associated symptoms include the following:
- Otalgia
- Hyperacusis (in up to 30% of the patients)
- Decreased tears
- Dysgeusia
- Facial or retroauricular pain
- Some believe that other cranial neuropathies may also be present, however; this is not uniformly accepted. The symptoms in question include the following:
- Hyperesthesia or dysesthesia of the glossopharyngeal or trigeminal nerves
- Dysfunction of the vestibular nerve
- Hyperesthesia of the cervical sensory nerves
- Vagal or trigeminal motor weakness
- IFP is often abrupt in onset; it usually evolves in less than 2 days.
- Progression of the paresis is possible, but it usually does not progress beyond 7-10 days. A progression beyond this point suggests a different diagnosis.
- If the facial paralysis progresses over weeks to months after the initial diagnosis, then the possibility of a neoplasm should be considered. These include parotid gland neoplasms that can manifest as asymmetric enlargement of the parotid gland or bulging of the parapharyngeal musculature.
- Tumors in the temporal bone such as facial nerve neuromas, meningiomas, hemangiomas, and malignant primary and metastatic lesions should be considered as well.
- Bell palsy rarely recurs. If facial paralysis returns after the initial resolution, another cause should be determined.
Physical
In the grading system developed by House and Brackmann, grades I and II are considered good outcomes, grades III and IV represent moderate dysfunction, and grades V and VI describe poor results. Grade VI is defined as complete facial paralysis; all the other grades are defined as incomplete. An incomplete facial paralysis denotes an anatomically, and to some degree functionally, intact nerve. The degree of facial nerve function should be noted in the chart at the initial visit of the patient.
- Grade I - Normal facial function
- Grade II - Mild dysfunction
- Slight weakness is noted on close inspection. The patients may have a slight synkinesis.
- Normal symmetry and tone is noted at rest.
- Forehead motion is moderate to good, complete eye closure is achieved with minimal effort, and slight mouth asymmetry is noted.
- Grade III - Moderate dysfunction
- An obvious but not disfiguring difference is noted between both the sides. A noticeable but not severe synkinesis, contracture, or hemifacial spasm is present.
- Normal symmetry and tone is noted at rest.
- Forehead movement is slight to moderate, complete eye closure is achieved with effort, and a slightly weak mouth movement is noted with maximum effort.
- Grade IV - Moderately severe dysfunction
- An obvious weakness and/or disfiguring asymmetry is noted.
- Symmetry and tone are normal at rest.
- No forehead motion is observed. Eye closure is incomplete, and an asymmetric mouth is noted with maximal effort.
- Grade V - Severe dysfunction
- Only a barely perceptible motion is noted.
- Asymmetry is noted at rest.
- No forehead motion is observed.
- Eye closure is incomplete and mouth movement is only slight.
- Grade VI - Total paralysis
- Gross asymmetry is noted.
- No movement is noted.
- Other findings: In addition to the facial nerve examination, a full examination of the ear as well as the neck should be performed.
- Otologic examination includes pneumatic otoscopy and tuning fork examination. An otologic cause should be considered if the history or physical examination demonstrates evidence of acute or chronic otitis media, including a tympanic membrane perforation, otorrhea, cholesteatoma, or granulation tissue, or if a history of previous ear surgery is noted. Vesicles may suggest Ramsay Hunt syndrome (herpes zoster oticus).
- Parotid/neck examination must be performed to rule out parotid malignancy as a possible cause.
- Neurologic examination includes complete examination of all the cranial nerves, sensory and motor testing, and cerebellar testing.
- Vesiculation with otalgia and facial pain, facial paralysis, and pruritus or burning may indicate herpes zoster oticus, also known as Ramsay-Hunt syndrome.
- All branches of the facial nerve are involved. If the divisions of the facial nerve are not involved, another cause either locally, such as leprosy, or within the CNS should be considered.
- Paralysis of the facial musculature with sparing of the forehead suggests a central pathology.
Causes
Viral infection, vascular compromise, autoimmune disease, and infectious agents are all proposed etiologies of IFP; the most widely accepted is a virally mediated cranial neuritis caused by the HSV.
Some studies have suggested a possible link to mycoplasma infection and the development of Bell palsy; the mechanism and etiology of this is unknown.1,2
More on Bell Palsy |
Overview: Bell Palsy |
| Differential Diagnoses & Workup: Bell Palsy |
| Treatment & Medication: Bell Palsy |
| Follow-up: Bell Palsy |
| References |
| Next Page » |
References
Völter C, Helms J, Weissbrich B, Rieckmann P, Abele-Horn M. Frequent detection of Mycoplasma pneumoniae in Bell's palsy. Eur Arch Otorhinolaryngol. Aug 2004;261(7):400-4. [Medline].
Papaevangelou V, Falaina V, Syriopoulou V, Theodordou M. Bell's palsy associated with Mycoplasma pneumoniae infection. Pediatr Infect Dis J. Nov 1999;18(11):1024-6. [Medline].
Adour KK, Byl FM, Hilsinger RL Jr, Kahn ZM, Sheldon MI. The true nature of Bell's palsy: analysis of 1,000 consecutive patients. Laryngoscope. May 1978;88(5):787-801. [Medline].
Adour KK, Ruboyianes JM, Von Doersten PG, Byl FM, Trent CS, Quesenberry CP Jr. Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol. May 1996;105(5):371-8. [Medline].
Adour KK, Sheldon MI, Kahn ZM. Maximal nerve excitability testing versus neuromyography: prognostic value in patients with facial paralysis. Laryngoscope. Sep 1980;90(9):1540-7. [Medline].
Adour KK, Wingerd J. Idiopathic facial paralysis (Bell's palsy): factors affecting severity and outcome in 446 patients. Neurology. Dec 1974;24(12):1112-6. [Medline].
Allen D, Dunn L. Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2004;(3):CD001869. [Medline].
Choi SH, Yoon TH, Lee KS. Blepharokymographic analysis of eyelid motion in Bell's palsy. Laryngoscope. 2007;117(2):308-12.
De Diego JI, Prim MP, Madero R, Gavilan J. Seasonal patterns of idiopathic facial paralysis: a 16-year study. Otolaryngol Head Neck Surg. Feb 1999;120(2):269-71. [Medline].
Fisch U. Surgery for Bell's palsy. Arch Otolaryngol. Jan 1981;107(1):1-11. [Medline].
Gantz BJ, Rubinstein JT, Gidley P, Woodworth GG. Surgical management of Bell's palsy. Laryngoscope. Aug 1999;109(8):1177-88. [Medline].
Hato N, Yamada H, Kohno H, Matsumoto S, Honda N, Gyo K. Valacyclovir and Prednisolone Treatment for Bell's Palsy: A Multicenter, Randomized, Placebo-Controlled Study. Otol Neurotol. Feb 5 2007;[Medline].
House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. Apr 1985;93(2):146-7. [Medline].
Hughes GB, Pensak ML. Facial nerve disorders. In: Clinical Otology. 2nd ed. New York, NY: Thieme Medical Publishers;1997:367-80.
Jackler RK, Brackmann DE. The acute facial palsies. In: Neurotology: Principles and Practice. St. Louis, Mo: Mosby-Year Book;1994:1291-5.
Kanoh N, Nomura J, Satomi F. Nocturnal onset and development of Bell's palsy. Laryngoscope. Jan 2005;115(1):99-100. [Medline].
Kawaguchi K, Inamura H, Abe Y. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. Laryngoscope. 2007;Jan;117(1):147-56.
Kress B, Griesbeck F, Stippich C, Bähren W, Sartor K. Bell palsy: quantitative analysis of MR imaging data as a method of predicting outcome. Radiology. Feb 2004;230(2):504-9. [Medline].
Murakami S, Mizobuchi M, Nakashiro Y, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. Jan 1 1996;124(1 Pt 1):27-30. [Medline].
Mutsch M, Zhou W, Rhodes P, et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med. Feb 26 2004;350(9):896-903. [Medline].
Peitersen E. The natural history of Bell's palsy. Am J Otol. Oct 1982;4(2):107-11. [Medline].
Pulec JL. Early decompression of the facial nerve in Bell's palsy. Ann Otol Rhinol Laryngol. Nov-Dec 1981;90(6 Pt 1):570-7. [Medline].
Salinas RA, Alvarez G, Ferreira J. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2004;(4):CD001942. [Medline].
Stowe J, Andrews N, Wise L. Bell's palsy and parenteral inactivated influenza vaccine. Hum Vaccin. 2006;2(3):110-2.
Yanagihara N, Hato N, Murakami S, Honda N. Transmastoid decompression as a treatment of Bell palsy. Otolaryngol Head Neck Surg. Mar 2001;124(3):282-6. [Medline].
Further Reading
Keywords
Bell palsy, Bell's palsy, BP, acute facial paralysis, idiopathic facial paralysis, IFP, facial palsy, lower motor neuron facial paresis, lower motor neuron facial paralysis, cranial nerve VII, CN VII
Overview: Bell Palsy